Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Q57278891)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

0 references

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Vesa Kataja

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2

S D Fosså

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

ESMO Guidelines Working Group

23 February 2020

10

object named as

ESMO Guidelines Working Group

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

J Oldenburg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

J Nuver

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Heidenreich

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

H-J Schmoll

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

C Bokemeyer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Horwich

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

1 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

24 Suppl 6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

suppl 6

0 references

page(s)

vi125-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Late recurrences of germ cell malignancies: a population-based experience over three decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Neoadjuvant carboplatin before radiotherapy in stage IIA and IIB seminoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Ca

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Medical treatment of advanced testicular cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Long-term follow-up of Cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Late relapses of germ cell malignancies: incidence, management, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Paternity following treatment for testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Early development of the metabolic syndrome after chemotherapy for testicular cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

Trends in testicular cancer incidence and mortality in 22 European countries: Continuing increases in incidence and declines in mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT304

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDT304

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24078656%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference